Publishing in a heart failure journal-where lies the scientific interest?
作者信息
Emami Amir, Ebner Nicole, von Haehling Stephan
机构信息
Department of Cardiology and Pneumology, University of Göttingen Medical Center, Robert-Koch-Strasse 40, D-37075, Göttingen, Germany.
出版信息
ESC Heart Fail. 2017 Nov;4(4):389-401. doi: 10.1002/ehf2.12233. Epub 2017 Nov 13.
Abstract
摘要
相似文献
1
Publishing in a heart failure journal-where lies the scientific interest?在心力衰竭领域的期刊上发表文章——科学兴趣何在？
ESC Heart Fail. 2017 Nov;4(4):389-401. doi: 10.1002/ehf2.12233. Epub 2017 Nov 13.
2
The Scientific Integrity of Journal Publications in the Age of 'Fake News'.“假新闻”时代期刊出版物的科学诚信
J Trop Pediatr. 2018 Oct 1;64(5):360-363. doi: 10.1093/tropej/fmy039.
3
Writing the introduction.撰写引言。
Singapore Med J. 2008 Oct;49(10):756-7; quiz758.
4
The European Heart Journal and the European Journal of Heart Failure: partners in scientific publishing.《欧洲心脏杂志》与《欧洲心力衰竭杂志》：科学出版领域的合作伙伴。
Eur J Heart Fail. 2012 Oct;14(10):1075-82. doi: 10.1093/eurjhf/hfs137. Epub 2012 Sep 12.
5
Conflict of interest. The new McCarthyism in science.
JAMA. 1993 Jun 2;269(21):2782-4. doi: 10.1001/jama.269.21.2782.
6
Conflict of interest and the BMJ.利益冲突与《英国医学杂志》
BMJ. 1994 Jan 1;308(6920):4-5. doi: 10.1136/bmj.308.6920.4.
7
Simplicity and complexity in conflict of interest.
Science. 1993 Jul 2;261(5117):11. doi: 10.1126/science.8316842.
8
Enhancement of the impact of manuscript submissions to BMC: an editorial perspective.提高向《BMC》投稿的影响力：编辑视角
Biomed Chromatogr. 2009 Jan;23(1):1-2. doi: 10.1002/bmc.1169.
9
Editorials and conflicts of interest.社论与利益冲突。
N Engl J Med. 1996 Oct 3;335(14):1055-6. doi: 10.1056/NEJM199610033351410.
10
Ensuring Scientific Publishing Credibility in Translational Biomedical Optics.确保转化生物医学光学领域的科学出版可信度。
J Biomed Opt. 2019 Jan;24(1):1-3. doi: 10.1117/1.JBO.24.1.010101.
本文引用的文献
1
Reframing the association and significance of co-morbidities in heart failure.重新构建心力衰竭共病的关联和意义。
Eur J Heart Fail. 2016 Jul;18(7):744-58. doi: 10.1002/ejhf.600. Epub 2016 Jun 30.
2
European Society of Cardiology Heart Failure Long-Term Registry (ESC-HF-LT): 1-year follow-up outcomes and differences across regions.欧洲心脏病学会心力衰竭长期注册研究（ESC-HF-LT）：1 年随访结果及各地区差异。
Eur J Heart Fail. 2016 Jun;18(6):613-25. doi: 10.1002/ejhf.566.
3
Efficacy of sacubitril/valsartan vs. enalapril at lower than target doses in heart failure with reduced ejection fraction: the PARADIGM-HF trial.沙库巴曲缬沙坦与依那普利在低于目标剂量时对射血分数降低的心力衰竭的疗效：PARADIGM-HF试验
Eur J Heart Fail. 2016 Oct;18(10):1228-1234. doi: 10.1002/ejhf.580. Epub 2016 Jun 10.
4
Heart failure epidemiology 2000-2013: insights from the German Federal Health Monitoring System.心力衰竭流行病学 2000-2013：来自德国联邦健康监测系统的见解。
Eur J Heart Fail. 2016 Aug;18(8):1009-18. doi: 10.1002/ejhf.567. Epub 2016 Jun 1.
5
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.2016欧洲心脏病学会急性和慢性心力衰竭诊断与治疗指南：欧洲心脏病学会（ESC）急性和慢性心力衰竭诊断与治疗工作组编写，欧洲心脏病学会心力衰竭协会（HFA）提供特别贡献。
Eur Heart J. 2016 Jul 14;37(27):2129-2200. doi: 10.1093/eurheartj/ehw128. Epub 2016 May 20.
6
Initiating sacubitril/valsartan (LCZ696) in heart failure: results of TITRATION, a double-blind, randomized comparison of two uptitration regimens.在心力衰竭患者中起始使用沙库巴曲缬沙坦（LCZ696）：TITRATION研究结果，一项关于两种滴定方案的双盲、随机对照比较研究
Eur J Heart Fail. 2016 Sep;18(9):1193-202. doi: 10.1002/ejhf.548. Epub 2016 May 12.
7
Physicians' adherence to guideline-recommended medications in heart failure with reduced ejection fraction: data from the QUALIFY global survey.心力衰竭射血分数降低患者的医生遵循指南推荐药物情况：来自 QUALIFY 全球调查的数据。
Eur J Heart Fail. 2016 May;18(5):514-22. doi: 10.1002/ejhf.510. Epub 2016 Apr 20.
8
Prevalence and prognostic impact of frailty and its components in non-dependent elderly patients with heart failure.非依赖型老年心力衰竭患者衰弱及其各组分的流行率和预后影响。
Eur J Heart Fail. 2016 Jul;18(7):869-75. doi: 10.1002/ejhf.518. Epub 2016 Apr 12.
9
The transcardiac gradient of cardio-microRNAs in the failing heart.心脏衰竭中心脏微 RNA 的跨心梯度。
Eur J Heart Fail. 2016 Aug;18(8):1000-8. doi: 10.1002/ejhf.517. Epub 2016 Apr 12.
10
Traditional and new composite endpoints in heart failure clinical trials: facilitating comprehensive efficacy assessments and improving trial efficiency.心力衰竭临床试验中的传统和新型复合终点：促进全面疗效评估和提高试验效率。
Eur J Heart Fail. 2016 May;18(5):482-9. doi: 10.1002/ejhf.516. Epub 2016 Apr 12.
Zotero 插件